Detection of catechol-O-methyltransferase Val158Met polymorphism by a simple one-step tetra-primer amplification refractory mutation system-PCR

Molecular and Cellular Probes

Volumn 21, Issue 3, 2007, Pages 202-207

  Ruiz Sanz, José Ignacio ^a   Aurrekoetxea, Igor ^a   del Agua, Ainhoa Ruiz ^a   Ruiz Larrea, María Begoña ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Amplification refractory mutation system (ARMS); Catechol O methyltransferase; Human polymorphism; SNP

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; MUTANT PROTEIN; PRIMER DNA; VALINE;

AMINO ACID SUBSTITUTION; AMPLICON; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; AMPLIFIED REFRACTORY MUTATION SYSTEM; ARTICLE; COMT GENE; CONTROLLED STUDY; DNA DETERMINATION; GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MUTATIONAL ANALYSIS; NEWBORN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; VALIDATION PROCESS;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CATECHOL O-METHYLTRANSFERASE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; INFANT, NEWBORN; MALE; METHIONINE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; VALINE;

TETRA;

EID: 33947131237     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcp.2006.12.001     Document Type: Article

References (35)

1. Axelrod J., and Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233 (1958) 702-705
2. Guldberg H.C., and Marsden C.A. Catechol-O-methyl transferase: pharmacological aspects and physiological role. Pharmacol Rev 27 (1975) 135-206
3. Farinati F., Cardin R., Bortolami M., Grottola A., Manno M., Colantoni A., et al. Estrogens receptors and oxidative damage in the liver. Mol Cell Endocrinol 193 (2002) 85-88
4. Liu X., Yao J., Pisha E., Yang Y., Hua Y., van Breemen R.B., et al. Oxidative DNA damage induced by equine estrogen metabolites: role of estrogen receptor alpha. Chem Res Toxicol 15 (2002) 512-519
5. Felty Q., Xiong W.C., Sun D., Sarkar S., Singh K.P., Parkash J., et al. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44 (2005) 6900-6909
6. Felty Q., and Roy D. Mitochondrial signals to nucleus regulate estrogen-induced cell growth. Med Hypotheses 64 (2005) 111-133
7. Bertocci B., Miggiano V., Da P.M., Dembic Z., Lahm H.W., and Malherbe P. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 88 (1991) 1416-1420
8. Lundstrom K., Salminen M., Jalanko A., Savolainen R., and Ulmanen I. Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol 10 (1991) 181-189
9. Mannisto P.T., and Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51 (1999) 593-628
10. Grossman M.H., Emanuel B.S., and Budarf M.L. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1···q11.2. Genomics 12 (1992) 822-825
11. Winqvist R., Lundstrom K., Salminen M., Laatikainen M., and Ulmanen I. The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI. Cytogenet Cell Genet 59 (1992) 253-257
12. Lavigne J.A., Helzlsouer K.J., Huang H.Y., Strickland P.T., Bell D.A., Selmin O., et al. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res 57 (1997) 5493-5497
13. Thompson P.A., Shields P.G., Freudenheim J.L., Stone A., Vena J.E., Marshall J.R., et al. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58 (1998) 2107-2110
14. McGrath M., Hankinson S.E., Arbeitman L., Colditz G.A., Hunter D.J., and De Vivo I. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis 25 (2004) 559-565
15. Cheng T.C., Chen S.T., Huang C.S., Fu Y.P., Yu J.C., Cheng C.W., et al. Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility. Int J Cancer 113 (2005) 345-353
16. Inoue H., Shibuta K., Matsuyama A., Yoshinaga K., Sadanaga N., Ueo H., et al. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer. Oncol Rep 14 (2005) 707-712
17. Wen W., Cai Q., Shu X.O., Cheng J.R., Parl F., Pierce L., et al. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis. Cancer Epidemiol Biomarkers Prev 14 (2005) 329-335
18. Lin W.Y., Chou Y.C., Wu M.H., Jeng Y.L., Huang H.B., You S.L., et al. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan. Cancer Detect Prev 29 (2005) 427-432
19. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., et al. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
20. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
21. Saiki R.K., Scharf S., Faloona F., Mullis K.B., Horn G.T., Erlich H.A., et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230 (1985) 1350-1354
22. Fischer S.G., and Lerman L.S. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 80 (1983) 1579-1583
23. Saiki R.K., Bugawan T.L., Horn G.T., Mullis K.B., and Erlich H.A. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 324 (1986) 163-166
24. Yang B., Viscidi R., and Yolken R. Quantitative measurement of nonisotopically labeled polymerase chain reaction product. Anal Biochem 213 (1993) 422-425
25. Orita M., Iwahana H., Kanazawa H., Hayashi K., and Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86 (1989) 2766-2770
26. Newton C.R., Graham A., Heptinstall L.E., Powell S.J., Summers C., Kalsheker N., et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17 (1989) 2503-2516
27. Ye S., Dhillon S., Ke X., Collins A.R., and Day I.N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29 (2001) E88
28. Okayama N., Fujimura K., Nakamura J., Suehiro Y., Hamanaka Y., and Hinoda Y. Evaluation of a new efficient procedure for single-nucleotide polymorphism genotyping: tetra-primer amplification refractory mutation system-polymerase chain reaction. Clin Chem Lab Med 42 (2004) 13-16
29. Hoda F., Nicholl D., Bennett P., Arranz M., Aitchison K.J., al-Chalabi A., et al. No association between Parkinson's disease and low-activity alleles of catechol-O-methyltransferase. Biochem Biophys Res Commun 228 (1996) 780-784
30. Syvanen A.C., Tilgmann C., Rinne J., and Ulmanen I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 7 (1997) 65-71
31. Goodman M.T., McDuffie K., Kolonel L.N., Terada K., Donlon T.A., Wilkens L.R., et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10 (2001) 209-216
32. Tempfer C.B., Riener E.K., Hefler L.A., Huber J.C., and Muendlein A. DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy. Fertil Steril 82 (2004) 132-137
33. McLeod H.L., Syvanen A.C., Githang'a J., Indalo A., Ismail D., Dewar K., et al. Ethnic differences in catechol-O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals. Pharmacogenetics 8 (1998) 195-199
34. Palmatier M.A., Kang A.M., and Kidd K.K. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46 (1999) 557-567
35. Lee M.S., Kim H.S., Cho E.K., Lim J.H., and Rinne J.O. COMT genotype and effectiveness of entacapone in patients with fluctuating Parkinson's disease. Neurology 58 (2002) 564-567